)
)
)
NeuroTherapia, Inc.
NeuroTherapia is a clinical stage company developing an orally available molecule to treat neuroinflammation. NeuroTherapia has started a Phase 2a trial with AD subjects and is interested in meeting with companies to discuss the Phase 2a results, which will be available in late Q1 or early Q2 of 2026, and potential partnering opportunities.
Address
ClevelandOhio
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)